Alex Wasyl, Nexien BioPharma CEO, Returns to The Big Biz

Alex Wasyl, Nexien BioPharma CEO, interviewed by The Big Biz Show to discuss the trends of of state-sanctioned medical and adult-use cannabis, and the emerging growth of FDA approved cannabinoid pharmaceuticals.

Nexien BioPharma CEO, Alex Wasyl joins The Big Biz show to discuss the development of cannabinoid pharmaceuticals for FDA approval.

Wasyl discusses the emerging cannabinoid pharmaceutical space, showcases Nexien BioPharma's drug development programs, and sheds light on the current federal regulatory environment surrounding treating cannabinoids as active pharmaceutical ingredients (APIs).